Details for New Drug Application (NDA): 010379

NDA 010379 describes CYTOMEL, which is a drug marketed by King Pharms and is included in one NDA. It is available from two suppliers. Additional details are available on the CYTOMEL profile page.

The generic ingredient in CYTOMEL is liothyronine sodium. There are four drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the liothyronine sodium profile page.

Summary for 010379

Tradename:	CYTOMEL
Applicant:	King Pharms
Ingredient:	liothyronine sodium
Patents:	0

Pharmacology for NDA: 010379

Suppliers and Packaging for NDA: 010379

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
CYTOMEL	liothyronine sodium	TABLET;ORAL	010379	NDA AUTHORIZED GENERIC	Greenstone LLC	59762-1206	59762-1206-1	100 TABLET in 1 BOTTLE (59762-1206-1)
CYTOMEL	liothyronine sodium	TABLET;ORAL	010379	NDA AUTHORIZED GENERIC	Greenstone LLC	59762-1207	59762-1207-1	100 TABLET in 1 BOTTLE (59762-1207-1)

Profile for product number 001

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 0.005MG BASE
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 002

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 0.025MG BASE
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Profile for product number 003

Active Rx/OTC/Discontinued:	RX	Dosage:	TABLET;ORAL			Strength	EQ 0.05MG BASE
Approval Date:	Approved Prior to Jan 1, 1982	TE:	AB	RLD:	Yes

Complete Access Available with Subscription